{"text": ["UPDATE", "1-Canada", "to", "authorize", "use", "of", "Pfizer's", "COVID-19", "vaccine", "for", "children", "-source"], "created_at": "2021-11-18 20:12:51"}
{"text": ["Pfizer", "CEO", "Talks", "About", "Covid", "Vaccines", "and", "What", "Comes", "Next:", "\u2018I", "Think", "We", "Are", "Undervalued.\u2019"], "created_at": "2021-11-18 19:26:00"}
{"text": ["Why", "Cardiff", "Oncology", "Shares", "Were", "Up", "More", "Than", "15%", "on", "Thursday"], "created_at": "2021-11-18 19:19:36"}
{"text": ["'Everyone", "is", "a", "little", "bit", "confused'", "about", "COVID-19", "vaccine", "mandates", "and", "rules:", "Doctor"], "created_at": "2021-11-18 18:56:37"}
{"text": ["Pfizer\u2019s", "XELJANZ\u00ae", "(tofacitinib)", "Receives", "Marketing", "Authorization", "in", "the", "European", "Union", "for", "the", "Treatment", "of", "Active", "Ankylosing", "Spondylitis"], "created_at": "2021-11-18 18:30:00"}
{"text": ["FDA", "reviews", "mRNA", "booster", "shots", "for", "all", "adults", "ahead", "of", "holiday", "travel"], "created_at": "2021-11-18 17:20:02"}
{"text": ["Face", "masks", "and", "distancing", "are", "most", "effective", "measures", "in", "reducing", "COVID-19", "spread,", "study", "finds,", "as", "experts", "clamor", "for", "U.S.", "to", "expand", "booster", "program"], "created_at": "2021-11-18 15:56:00"}
{"text": ["Pfizer", "Again,", "Macy's,", "GlobalFoundries:", "3", "Things", "to", "Watch"], "created_at": "2021-11-18 15:47:37"}
{"text": ["U.S.", "Buys", "10", "Million", "Treatment", "Courses", "of", "Pfizer\u2019s", "Covid-19", "Pill", "for", "$5.29", "Billion"], "created_at": "2021-11-18 15:47:00"}
{"text": ["Pharma", "Stock", "Roundup:", "JNJ", "to", "Spin", "Off", "Consumer", "Unit,", "PFE", "Eyes", "EUA", "for", "COVID", "Pill"], "created_at": "2021-11-18 15:24:03"}
{"text": ["Pfizer", "to", "Be", "Paid", "$5.29", "Billion", "From", "U.S.", "Government", "for", "Covid-19", "Oral", "Pill"], "created_at": "2021-11-18 15:11:00"}
{"text": ["CureVac's", "COVID-19", "Vax", "Shows", "Comparable", "Antibody", "Levels", "To", "Pfizer/BioNTech's", "Shot", "In", "Animal", "Study"], "created_at": "2021-11-18 14:43:16"}
{"text": ["EU", "drug", "regulator", "aims", "to", "conclude", "Merck", "COVID-19", "antiviral", "pill", "approval", "by", "the", "end", "of", "2021"], "created_at": "2021-11-18 14:39:15"}
{"text": ["Italy", "to", "acquire", "50,000", "courses", "for", "each", "of", "Merck,", "Pfizer", "COVID-19", "antiviral", "drugs"], "created_at": "2021-11-18 14:31:39"}
{"text": ["Cardiff", "Oncology", "Stock", "Rises", "After", "$15M", "Equity", "Investment", "From", "Pfizer"], "created_at": "2021-11-18 14:30:05"}
{"text": ["Pfizer", "to", "supply", "U.S.", "government", "with", "10", "million", "doses", "of", "its", "antiviral", "for", "$5.29", "billion"], "created_at": "2021-11-18 14:08:19"}
{"text": ["These", "3", "High-Yield", "Dividend", "Stocks", "Are", "Growing", "at", "Blazing", "Speeds"], "created_at": "2021-11-18 13:54:26"}
{"text": ["CureVac", "Stock", "Climbs", "as", "Early", "Data", "Show", "Hope", "for", "Second", "Try", "at", "Covid", "Vaccine"], "created_at": "2021-11-18 13:20:00"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Eli", "Lilly,", "Pfizer", "and", "Novo", "Nordisk"], "created_at": "2021-11-18 12:28:12"}
{"text": ["Pfizer", "seeks", "emergency", "U.S.", "authorization", "for", "10", "million", "doses", "of", "new", "COVID-19", "anti", "viral", "drug"], "created_at": "2021-11-18 12:05:50"}
{"text": ["Cardiff", "Oncology", "Announces", "$15", "Million", "Equity", "Investment", "from", "Pfizer", "through", "its", "Pfizer", "Breakthrough", "Growth", "Initiative"], "created_at": "2021-11-18 12:00:00"}
{"text": ["UPDATE", "5-U.S.", "to", "buy", "10", "mln", "courses", "of", "Pfizer's", "COVID-19", "pill", "for", "$5.3", "bln"], "created_at": "2021-11-18 11:57:23"}
{"text": ["Should", "Pfizer", "Investors", "Expect", "a", "Big", "Dividend", "Hike", "in", "2022?"], "created_at": "2021-11-18 11:50:00"}
{"text": ["Pfizer", "to", "Provide", "U.S.", "Government", "with", "10", "Million", "Treatment", "Courses", "of", "Investigational", "Oral", "Antiviral", "Candidate", "to", "Help", "Combat", "COVID-19"], "created_at": "2021-11-18 11:45:00"}
{"text": ["Pfizer", "Gains", "on", "$5.29", "Billion", "Deal", "with", "U.S.", "for", "Covid-19", "Pill"], "created_at": "2021-11-18 10:56:26"}
{"text": ["AstraZeneca", "Says", "Preventive", "Covid", "Antibody", "Drug", "Reduces", "Risk", "by", "83%"], "created_at": "2021-11-18 10:38:00"}
{"text": ["Pfizer", "Stock", "Gains", "On", "$5.3", "Billion", "COVID", "Pill", "Treatment", "Deal", "With", "US", "Government"], "created_at": "2021-11-18 09:55:00"}
{"text": ["Companies", "make", "progress", "tackling", "drug-resistant", "infections,", "foundation", "says"], "created_at": "2021-11-18 00:01:00"}
